Doctor hunts for top-quality stool donors in Boston

Elizabeth Hohmann, an infectious disease specialist at Massachusetts General Hospital, spends her days screening potential stool donors for faecal transplants that treat stubborn gut infections. With only about one percent of respondents qualifying, the process is challenging but rewarding. Her work has restored health to patients who previously couldn't function normally.

For 15 years, Elizabeth Hohmann has led the faecal transplant program at Massachusetts General Hospital in Boston, transforming donated stools into oral capsules to combat recurrent Clostridioides difficile infections. These infections, which cause severe diarrhoea and resist antibiotics, affect many patients, but the transplants introduce beneficial gut bacteria to outcompete the harmful ones.

Finding suitable donors is no easy task. Hohmann advertises online, offering $1,200 for a month's donations, yet only around one percent pass the rigorous checks. Candidates must avoid being healthcare workers or recent travellers to South-East Asia due to risks of drug-resistant bacteria, and they need to be lean to prevent obesity transmission. Successful applicants undergo blood tests for infections like HIV and covid-19, plus a rectal exam for gut issues.

Ideal donors are often fitness buffs with diets heavy on fruits, vegetables, and whole grains, shunning ultra-processed foods. Hohmann notes that while some centres prefer vegans, her top donors have been omnivores. Donations occur over two to four weeks, with donors visiting the hospital daily for bowel movements, often prompted by coffee. The fresh stool is blended with saline, filtered, and encapsulated promptly.

Post-donation re-screening ensures no new infections, like Salmonella, have arisen. The impact is profound: one patient, previously too ill to work, now manages 30 hours weekly. 'I keep doing it because it really does make a huge difference in some people’s lives,' Hohmann says. As retirement nears, she struggles to find a successor, with colleagues recoiling at the hands-on nature of the job.

相关文章

Illustration of glowing engineered bacterial pills detecting gut bleeding in a mouse intestine model.
AI 生成的图像

Engineered bacterial ‘pills’ show promise for detecting gut bleeding in mice

由 AI 报道 AI 生成的图像 事实核查

Researchers have developed tiny ingestible hydrogel microspheres packed with engineered bacteria that glow when they encounter blood in the gut, potentially offering a quick, noninvasive way to monitor intestinal disease. In mouse models of colitis, the sensors detected heme — a component of blood — within minutes and produced stronger signals as disease severity increased.

A small clinical trial shows that faecal microbiota transplants can improve outcomes for kidney cancer patients on immunotherapy drugs. Participants receiving transplants experienced longer cancer stability and greater tumor shrinkage compared to those given placebos. The approach targets the gut microbiome to boost immune responses against tumors.

由 AI 报道

A retired US Marine officer in Massachusetts, plagued by a gut that brewed its own alcohol, has seen his symptoms resolve after receiving faecal transplants from a healthy donor. The treatment targeted the rare auto-brewery syndrome, where gut microbes ferment sugars into intoxicating levels of alcohol. This case highlights potential new avenues for managing the condition triggered by antibiotic use.

一位英国内容创作者为更快治疗胃痛飞往北京,这凸显了外国人转向中国医疗体系寻求及时且负担得起的护理的趋势。她的经历反映了中国医院在效率和成本方面的优势,吸引了更多 expatriates 和前居民。

由 AI 报道

A new study reveals that chemotherapy's damage to the gut lining unexpectedly rewires the microbiota, producing a compound that strengthens immune defenses against cancer spread. This process reduces immunosuppressive cells and enhances resistance to metastasis, particularly in the liver. Patient data links higher levels of this compound to improved survival in colorectal cancer cases.

Researchers have identified 50 bacterial species strongly associated with markers of good health in the gut microbiome, based on data from over 34,000 people. The findings highlight links to cholesterol control, reduced inflammation, and better blood sugar management. This work aims to define what constitutes a healthy microbial community amid ongoing debates over its composition.

由 AI 报道 事实核查

Researchers led by Helmholtz Munich report that some gut-dwelling bacteria — including strains not typically considered harmful — possess syringe-like molecular machinery that can deliver bacterial proteins into human cells, affecting immune and metabolic signaling. The work also links these bacterial “effector” genes to Crohn’s disease–associated microbiome patterns, though the authors say more studies are needed to determine how the mechanism influences disease.

 

 

 

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝